Evidence map›Paper›PMID 36455956›Full record

ArticleJournal of investigative medicine : the official publication of the American Federation for Clinical Research2022

Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011-2020.

Fang Xu, Yong Liu, Kurt Greenlund, Susan Carlson

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fang XuDivision of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA vmf7@cdc.gov.ORCID 0000-0002-3975-5131
Yong LiuDivision of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kurt GreenlundDivision of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Susan CarlsonDivision of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Prescriptions for biologic therapy for treatment of Crohn's disease (CD) and ulcerative colitis (UC) have increased during the past two decades; however, trends are less clear regarding corticosteroid prescriptions in this context. We designed a cross-sectional study using the IQVIA Ambulatory Electronic Medical Records databases. Weighted linear regressions by age group were used to estimate annual percentage change from 2011 to 2020 in prescriptions for biologics and for corticosteroids among patients with or without biologic prescriptions within the same calendar year. Using 2019 data, we compared patient demographic and lifestyle risk factors using χ

Indexed as

Biological ProductsColitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesAdrenal Cortex HormonesChronic DiseaseCross-Sectional StudiesDemographyDrug PrescriptionsElectronic Health RecordsFemaleHumansMaleAdrenal Cortex HormonesBiological Productsanti-inflammatory agentsanti-inflammatory agents, non-steroidalinflammatory bowel diseases

Identifiers

PMID36455956
PMCPMC10468819
OpenAlexW4294636926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.